Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Tourmaline Bio Inc shares valued at $26,418 were purchased by Kulkarni Sandeep Chidambar on Aug 21 ’24. At $14.85 per share, Kulkarni Sandeep Chidambar acquired 1,779 shares. The insider’s holdings grew to 7,000 shares worth approximately $0.12 million following the completion of this transaction.
Also, Kulkarni Sandeep Chidambar purchased 5,221 shares, netting a total of over 71,998 in proceeds. Following the buying of shares at $13.79 each, the insider now holds 5,221 shares.
As published in their initiating research note from Chardan Capital Markets on April 23, 2025, Tourmaline Bio Inc [TRML] has been a Buy and the price target has been revised to $70. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in early March. As of December 06, 2024, BMO Capital Markets has initiated its “an Outperform” rating for TRML. Earlier on November 11, 2024, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for TRML stock.
Analyzing TRML Stock Performance
During the last five days, there has been a surge of approximately 19.36%. Over the course of the year, Tourmaline Bio Inc shares have dropped approximately -12.13%. Shares of the company reached a 52-week high of $22.21 on 01/07/25 and a 52-week low of $11.56 on 04/10/25. A 50-day SMA is recorded $14.60, while a 200-day SMA reached $19.09.
Support And Resistance Levels for Tourmaline Bio Inc (TRML)
According to the 24-hour chart, there is a support level at 17.45, which, if violated, would cause prices to drop to 17.08. In the upper region, resistance lies at 18.30. The next price resistance is at 18.78. RSI (Relative Strength Index) is 66.39 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.02, which suggests the price will increase in the coming days. Percent R is at 8.57%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
